NuVasive (NUVA) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for NuVasive (NUVA) over the last 10 years.
|Medical||Medical Products Manufacturing||$2.605B||$1.030B|
|NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.|